Chest pain is one of the commonest reasons for attending an emergency department, yet only about one patient in ten is ultimately diagnosed with an acute coronary syndrome [3]. A chest pain pathway therefore has two jobs: to identify the patients with acute coronary syndrome or another dangerous diagnosis quickly, and to discharge the low-risk majority without unnecessary admission or testing.
The 2021 AHA/ACC chest pain guideline recommends high-sensitivity cardiac troponin as the preferred biomarker and the use of structured clinical decision pathways [1, 9]. The European Society of Cardiology guideline on acute coronary syndromes without persistent ST elevation sets out rapid troponin algorithms and the timing of invasive management [2]. Both place the history and the ECG ahead of any number.